FAKTOR-OPTIONSSCHEIN - SMITH & NEPHEW | Market Closed - Börse Stuttgart 15:14:51 28/06/2024 BST | ||
| 7.51 EUR | +2.60% |
|
| Current month | -20.61% | ||
| 1 month | -16.56% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
SMITH & NEPHEW PLC
Latest news about SMITH & NEPHEW PLC
More news
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 7.51 | +2.60% |
| 27/06/24 | 7.32 | -10.40% |
| 26/06/24 | 8.17 | +5.56% |
| 25/06/24 | 7.74 | -12.15% |
| 24/06/24 | 8.81 | -9.36% |
Delayed Quote Börse Stuttgart
Last update June 28, 2024 at 03:14 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | SMITH & NEPHEW PLC |
| Issuer | Morgan Stanley |
| WKN | MG2WPX |
| ISIN | DE000MG2WPX7 |
| Date issued | 24/04/2024 |
| Strike | 854.8 p |
| Maturity | Unlimited |
| Parity | 0.2 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.35 € |
|---|---|
| Lowest since issue | 7.32 € |
| Spread | 0.07 € |
| Spread % | 0.93% |
Company Profile
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Sector
-
Consensus: Smith & Nephew Plc
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
12.39
USD
Average target price
16.36
USD
Spread / Average Target
+32.01%
- Stock Market
- Certificates
- Certificat
